Skip to main content
×
Login
Submit a Manuscript
Home
Journal
Current Issue
Archive
For Authors
Column Series
Research & Insight
Special Reports
Subscribe
Resources
Biosimilars Excellence Forum
Blogs
Expert Insights
Latest News
Mantle Cell Lymphoma Excellence Forum
Pathways Beyond Oncology
Topics
Comparative Effectiveness Research
Cost-Effectiveness Research
COVID-19 Updates
Guideline Updates
Health Economics and Outcomes Research
Health Technology
Real-World Data
Reimbursement
Value-Based Care
Specialties
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
B-Cell Lymphoma
Biosimilars
Bladder Cancer
Breast Cancer
CAR-T Therapies
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Cancer
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Immuno-Oncology
Kidney Cancer
Liver Cancer
Lung Cancer
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Skin Cancer
Supportive Care
Conferences
Oncology Clinical Pathways Congress
ASCO Gastrointestinal Cancers Symposium
ASCO Genitourinary Cancers Symposium
ASH Annual Meeting and Exposition
Oncology CME
About
About Us
Contact
Columns
Pharma Insights
Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic
Elizabeth Oyekan, PharmD, FCSHP, CPHQ February 22, 2021
Pharma Insights
ACOs: Changing Health Care Cost and Quality to Be Accountable
Marylou Buyse, MD, MS; Maureen Hennessey, PhD, CPCC, CPHQ; Larry Blandford, PharmD—Column Editor, December 13, 2018
If CMS is able to successfully move the market to ACOs or its other risk-based models, the market will respond and…
Clinical Pathways GPS
Value-Based Clinical Pathways in the World of Reference-Priced Medicare Part B Drugs
Matthew Pakizegee, PharmD, MS; Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor, December 13, 2018
Such a proposal, if enacted, would have far-reaching implications for clinical pathways developers and in terms of…
CME Corner
Prognostication and Treatment of Diffuse Large B-cell Lymphoma
Chadi Nabhan, MD, MBA, FACP, December 05, 2018
DLBCL is a very common lymphoma seen in clinical practice and, for the most part, R-CHOP given every 21 days remains…
Pharma Insights
Will Any Value Frameworks Gain Acceptance as an Informal Health Technology Assessment in the United States?
Stephanie Kennedy, PhD; Tricia Garland; Todd Edgar, PharmD, MS, SVP; Larry Blanford, PharmD—Column Editor , November 19, 2018
In this article, we will highlight therapy areas in which value frameworks are gaining traction, as well as the areas…
Business of Pathways
Engaging in Nontraditional Partnerships to Improve Population Health
Robert A Bailey, MD; Ira Klein, MD, MBA, FACP—Column Editor; Silas Martin, November 19, 2018
We provide examples of novel and effective partnerships that have recently been established between health care…
Clinical Pathways GPS
How the Proposed Elimination of Medicare Rebates Would Impact Clinical Pathways
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor, November 19, 2018
Clinical pathways can serve as a means to assist health systems make these assessments by integrating “beyond-the-pill…
Editorial
Charting a Path Forward for the Oncology Care Model
Nicolas Ferreyros, Director of Communications, Community Oncology Alliance, November 18, 2018
Editorial
Get to Know the Community Oncology Alliance
Nicolas Ferreyros, Director of Communications, Community Oncology Alliance, October 15, 2018
The Community Oncology Alliance and Journal of Clinical Pathways have joined in collaboration to keep JCP readers…
Clinical Pathways GPS
Addressing High Drug Costs: Integrating Value Assessment Principles Into Clinical Pathways
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor, Matthew Pakizegee, PharmD, MS, October 15, 2018
Clinical pathways offer a possible solution to the issue of therapy value assessment.
Patient Perspective
Talking About Costs of Care—Part Two: Integrating Discussions Into the Clinical Workflow
Alan Balch, PhD—Column Editor, October 15, 2018
In this Part 2 of the series, practical next steps are outlined that providers can take to ensure that these…
Pagination
First page
« First
Previous page
‹‹
…
Page
5
Page
6
Page
7
Page
8
Current page
9
Page
10
Page
11
Page
12
Page
13
…
Next page
››
Last page
Last »
Stay in the know.
Journal of Clinical Pathways Newsletter
Back to Top